Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

• Status: Completed
• Trial end date: 2012-08-14
• Target enrollment: 0
• Participant gender: All

Summary

This study will explore the dose-response of losartan as well as the safety and tolerability in children from 6 months to 6 years of age.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Losartan

Criteria

Inclusion Criteria:

• Participant is determined to be hypertensive

Exclusion Criteria:

• Participant has a history of severe or symptomatic hypertension

• Participant has history of heart failure, rhythm disturbance or cardiomyopathy, or obstructive valvular disease

• Participant has started taking hypertensive medications within the past 30 days

• Participant has a known sensitivity to losartan or history of angioneurotic edema